Implications for practice: phase II/III trial of carboplatin and irinotecan for elderly patients with extensive-stage small-cell lung cancer in Japan.

ABSTRACT:

SUBMITTER: Maheshwari S 

PROVIDER: S-EPMC11494565 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature